PET Scans for Rare & Uncommon Cancers – Are You Referring Eligible Patients?

At SRNM, we offer Medicare-funded FDG PET scans (Items 61612 & 61614) for the staging, treatment response, and recurrence of rare and uncommon cancers.

Did you know cancers like myeloma, pancreatic, uterine, HCC, and renal are on the eligible Medicare benefits list?

These are often under-referred – and patients could be missing out on the diagnostic power of PET.

For Item 61612: Benefits are payable once per diagnosis – make it count.  For both items: Ensure you clearly note “rare or uncommon cancer – meets MBS eligibility” on your referral.

• adrenocortical carcinoma
• anal cancer
• muscle-invasive bladder cancer
• primary brain cancer
• gallbladder and extrahepatic bile ducts (cancer of the)
• gastrointestinal stromal tumours (GIST)
• Kaposi sarcoma
• Langerhans cell histiocytosis (LCH)
• liver cancer
• Merkel cell cancer
• mesothelioma
• multiple myeloma
• neuroendocrine cancers (NECs)
• G2 & G3 neuroendocrine neoplasms (NETs)
• ovarian cancer and serous carcinomas of the fallopian tube
• pancreatic cancer
• parathyroid cancer
• penile cancer
• peritoneal cancer
• phaeochromocytoma/paraganglioma ([PPGL] malignant or syndromic)
• placenta cancer
• small cell lung cancer
• small intestine (cancer of the)
• stomach cancer
• testicular cancer
• thymic epithelial neoplasm (TETs)
• thyroid cancer (advanced)
• unknown primary site (cancer of)
• uterine cancer
• vaginal cancer
• vulvar cancer
• Wilms tumour

Fast access. Expert interpretation. Seamless care.

Got a case in mind? Refer directly or reach out to discuss eligibility. https://guest.foxo.com/chat/e6d7a83e-9574-4597-a4d2-c5f2c3b9d097/new